RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Wakamoto Pharmaceutical Co Stock

Wakamoto Pharmaceutical Co Debt 2024

Wakamoto Pharmaceutical Co Debt

-3,564.12 JPY

Ticker

4512.T

ISIN

JP3991200001

In 2024, Wakamoto Pharmaceutical Co's total debt was -3,564.12 JPY, a 13.9% change from the -3,129.24 JPY total debt recorded in the previous year.

Wakamoto Pharmaceutical Co Aktienanalyse

What does Wakamoto Pharmaceutical Co do?

Wakamoto Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Wakamoto Pharmaceutical Co's Debt Structure

Wakamoto Pharmaceutical Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Wakamoto Pharmaceutical Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Wakamoto Pharmaceutical Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Wakamoto Pharmaceutical Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Wakamoto Pharmaceutical Co stock

What is the debt of Wakamoto Pharmaceutical Co this year?

Wakamoto Pharmaceutical Co has a debt level of -3,564.12 JPY this year.

What was the debt of Wakamoto Pharmaceutical Co compared to the previous year?

The debt of Wakamoto Pharmaceutical Co has increased by 13.9% compared to the previous year increased.

What are the consequences of high debt for investors in Wakamoto Pharmaceutical Co?

High debt can pose a risk for investors of Wakamoto Pharmaceutical Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Wakamoto Pharmaceutical Co?

Low debt means that Wakamoto Pharmaceutical Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Wakamoto Pharmaceutical Co affect the company?

An increase in debt of Wakamoto Pharmaceutical Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Wakamoto Pharmaceutical Co affect the company?

A reduction in debt of Wakamoto Pharmaceutical Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Wakamoto Pharmaceutical Co?

Some factors that can influence the debt of Wakamoto Pharmaceutical Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Wakamoto Pharmaceutical Co so important for investors?

The debts of Wakamoto Pharmaceutical Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Wakamoto Pharmaceutical Co take to change the debt?

To change the debt, Wakamoto Pharmaceutical Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Wakamoto Pharmaceutical Co pay?

Over the past 12 months, Wakamoto Pharmaceutical Co paid a dividend of 3 JPY . This corresponds to a dividend yield of about 1.27 %. For the coming 12 months, Wakamoto Pharmaceutical Co is expected to pay a dividend of 3 JPY.

What is the dividend yield of Wakamoto Pharmaceutical Co?

The current dividend yield of Wakamoto Pharmaceutical Co is 1.27 %.

When does Wakamoto Pharmaceutical Co pay dividends?

Wakamoto Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Wakamoto Pharmaceutical Co?

Wakamoto Pharmaceutical Co paid dividends every year for the past 2 years.

What is the dividend of Wakamoto Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 3 JPY are expected. This corresponds to a dividend yield of 1.27 %.

In which sector is Wakamoto Pharmaceutical Co located?

Wakamoto Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Wakamoto Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Wakamoto Pharmaceutical Co from 6/1/2024 amounting to 3 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Wakamoto Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Wakamoto Pharmaceutical Co in the year 2023?

In the year 2023, Wakamoto Pharmaceutical Co distributed 3 JPY as dividends.

In which currency does Wakamoto Pharmaceutical Co pay out the dividend?

The dividends of Wakamoto Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Wakamoto Pharmaceutical Co

Our stock analysis for Wakamoto Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wakamoto Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.